FDA Inspection
Los Angeles General Medical CenterLos Angeles General Medical Center – FDA Inspection, Sep 30, 2009
Record Details
This FDA Inspection record concerns Los Angeles General Medical Center, with an inspection on September 30, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 30, 2009
- Product Type
- Biologics
View Company Profile
ID · c339ab0f-5ba5-4f1f-a35c-8123b7333fcc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 615708
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Los Angeles General Medical Center
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 7, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Los Angeles General Medical Center
- FDA Inspection 1245241 - 2024-07-19
- FDA Inspection 1085150 - 2019-03-20
- FDA Inspection 1017569 - 2017-06-15
- FDA Inspection 925621 - 2015-05-07
- FDA Inspection 848378 - 2013-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.